Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology
- PMID: 19052140
- PMCID: PMC2724914
- DOI: 10.1093/brain/awn323
Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology
Abstract
Parkinson's disease is caused by a progressive loss of the midbrain dopamine (DA) neurons in the substantia nigra pars compacta. Although the main cause of Parkinson's disease remains unknown, there is increasing evidence that it is a complex disorder caused by a combination of genetic and environmental factors, which affect key signalling pathways in substantia nigra DA neurons. Insights into pathogenesis of Parkinson's disease stem from in vitro and in vivo models and from postmortem analyses. Recent technological developments have added a new dimension to this research by determining gene expression profiles using high throughput microarray assays. However, many of the studies reported to date were based on whole midbrain dissections, which included cells other than DA neurons. Here, we have used laser microdissection to isolate single DA neurons from the substantia nigra pars compacta of controls and subjects with idiopathic Parkinson's disease matched for age and postmortem interval followed by microarrays to analyse gene expression profiling. Our data confirm a dysregulation of several functional groups of genes involved in the Parkinson's disease pathogenesis. In particular, we found prominent down-regulation of members of the PARK gene family and dysregulation of multiple genes associated with programmed cell death and survival. In addition, genes for neurotransmitter and ion channel receptors were also deregulated, supporting the view that alterations in electrical activity might influence DA neuron function. Our data provide a 'molecular fingerprint identity' of late-stage Parkinson's disease DA neurons that will advance our understanding of the molecular pathology of this disease.
Figures
Similar articles
-
Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.Brain. 2014 Aug;137(Pt 8):2287-302. doi: 10.1093/brain/awu131. Epub 2014 Jun 16. Brain. 2014. PMID: 24934288 Free PMC article.
-
Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death.Brain Pathol. 2009 Jan;19(1):91-107. doi: 10.1111/j.1750-3639.2008.00171.x. Epub 2008 May 7. Brain Pathol. 2009. PMID: 18462474 Free PMC article.
-
Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death.Acta Neuropathol. 2011 Jul;122(1):75-86. doi: 10.1007/s00401-011-0828-9. Epub 2011 May 4. Acta Neuropathol. 2011. PMID: 21541762
-
Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.J Neurochem. 2016 Oct;139 Suppl 1(Suppl Suppl 1):156-178. doi: 10.1111/jnc.13572. Epub 2016 Mar 23. J Neurochem. 2016. PMID: 26865375 Free PMC article. Review.
-
Environment- and activity-dependent dopamine neurotransmitter plasticity in the adult substantia nigra.J Chem Neuroanat. 2016 Apr;73:21-32. doi: 10.1016/j.jchemneu.2015.12.009. Epub 2015 Dec 21. J Chem Neuroanat. 2016. PMID: 26718607 Review.
Cited by
-
A micro-silicon chip for in vivo cerebral imprint in monkey.ACS Chem Neurosci. 2013 Mar 20;4(3):385-92. doi: 10.1021/cn300116g. Epub 2013 Jan 15. ACS Chem Neurosci. 2013. PMID: 23509975 Free PMC article.
-
Initial Molecular Mechanisms of the Pathogenesis of Parkinson's Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease.Int J Mol Sci. 2024 Jan 22;25(2):1354. doi: 10.3390/ijms25021354. Int J Mol Sci. 2024. PMID: 38279354 Free PMC article.
-
Systems level analysis of sex-dependent gene expression changes in Parkinson's disease.NPJ Parkinsons Dis. 2023 Jan 21;9(1):8. doi: 10.1038/s41531-023-00446-8. NPJ Parkinsons Dis. 2023. PMID: 36681675 Free PMC article.
-
In vivo overexpression of synaptogyrin-3 promotes striatal synaptic dopamine uptake in LRRK2R1441G mutant mouse model of Parkinson's disease.Brain Behav. 2023 Feb;13(2):e2886. doi: 10.1002/brb3.2886. Epub 2023 Jan 9. Brain Behav. 2023. PMID: 36624932 Free PMC article.
-
PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.Sci Transl Med. 2010 Oct 6;2(52):52ra73. doi: 10.1126/scitranslmed.3001059. Sci Transl Med. 2010. PMID: 20926834 Free PMC article.
References
-
- Benabid AL. What the future holds for deep brain stimulation. Expert Rev Med Devices. 2007;4:895–903. - PubMed
-
- Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch EC. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett. 1994;172:151–4. - PubMed
-
- Brunger AT. Structure and function of SNARE and SNARE-interacting proteins. Q Rev Biophys. 2005;38:1–47. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous